Pamela Davis is an Executive Medical Director at Intercept Pharmaceuticals, specializing in advancing medical affairs for chronic liver disease treatments. With over 40 years of experience in medicine, they have held key roles at several notable companies, including sanofi-aventis, Novartis, and Merck & Co. Inc. Their expertise encompasses medical strategy, clinical trials, and stakeholder engagement. Pamela's educational background includes a Doctor of Medicine degree from the Medical College of Virginia - VCU. Currently, they serve as the Director of External Scientific Collaborations for Rare Disease at Ipsen.
This person is not in any teams
This person is not in any offices